Comments

Viking Therapeutics (VKTX) Stock Price, Quote, News & History

VKTXNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$36.15
-0.93-2.51%
At close: Dec 15, 4:00 PM EST
$36.19
0.040.11%
After Hours: 4:03 PM EST

Overview

NewsEarningsOptionsAnalyst RatingsInsider TradesShort InterestStock Report
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open
$36.77
Close
$36.15
Volume / Avg.
1.93M / 4.38M
Day Range
$35.95 - $37.16
52 Wk Range
18.92 - 49.67
Market Cap
$4.09B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
24.38%
Days to Cover
7.77

Recent Viking Therapeutics Inc News

What's Happening With French Biotech Abivax Stock On Wednesday?

Abivax shares rise on renewed takeover speculation tied to Eli Lilly following strong Phase 3 trial results.
Vandana Singh

What's Up With The Jump In Viking Therapeutics Stock?

Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher on Thursday. The clinical-stage biopharmaceutical company seems to be benefitting from the wider excitement in obesity treatment area and the recent positive momentum after major clinical trial developments.
Evette Mitkov

3 Weight-Loss Drug Stocks To Consider For 2026

Benzinga Research Team

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Analyst Trends and Forecast

1
Aug
2
Sep
3
Oct
1
Nov
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Key Statistics

Open
$36.77
Close
$36.15
Volume / Avg.
1.93M / 4.38M
Day Range
$35.95 - $37.16
52 Wk Range
18.92 - 49.67
Market Cap
$4.09B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
24.38%
Days to Cover
7.77

About

Sector
Health Care
Industry
Biotechnology
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 pr...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
VKTX
IMVT

FAQ

Q

How do I buy Viking Therapeutics (VKTX) stock?

A

You can purchase shares of Viking Therapeutics (NASDAQ:VKTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Viking Therapeutics (VKTX) competitors?

Q

What is the forecast, or price target, for Viking Therapeutics (VKTX) stock?

A

Viking Therapeutics has a consensus price target of $80.55.

Q

What is the current price for Viking Therapeutics (VKTX)?

A

The stock price for Viking Therapeutics (NASDAQ: VKTX) is $36.19 last updated December 15, 2025 at 4:03 PM EST.

Q

Does Viking Therapeutics (VKTX) pay a dividend?

A

There are no upcoming dividends for Viking Therapeutics.

Q

When is Viking Therapeutics (NASDAQ:VKTX) reporting earnings?

A

Viking Therapeutics does not have any upcoming earnings scheduled.

Q

Is Viking Therapeutics (VKTX) going to split?

A

There is no upcoming split for Viking Therapeutics.

Q

What sector and industry does Viking Therapeutics (VKTX) operate in?

A

Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Immunovant Inc
NASDAQ:IMVT
$26.00
%
Legend Biotech Corp
NASDAQ:LEGN
$21.93
-0.36%
Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
$36.23
%
Celcuity Inc
NASDAQ:CELC
$102.18
%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
$26.15
%
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
$28.87
-0.28%
Alkermes PLC
NASDAQ:ALKS
$28.23
0.21%
Xenon Pharmaceuticals Inc
NASDAQ:XENE
$43.60
%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved